Cargando…

The impact of comorbidities on productivity loss in asthma patients

BACKGROUND: Health-related productivity loss is an important, yet overlooked, component of the economic burden of disease in asthma patients of a working age. We aimed at evaluating the effect of comorbidities on productivity loss among adult asthma patients. METHODS: In a random sample of employed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ehteshami-Afshar, Solmaz, FitzGerald, J. Mark, Carlsten, Christopher, Tavakoli, Hamid, Rousseau, Roxanne, Tan, Wan Cheng, Rolf, J. Douglass, Sadatsafavi, Mohsen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5002149/ https://www.ncbi.nlm.nih.gov/pubmed/27565431 http://dx.doi.org/10.1186/s12931-016-0421-9

Ejemplares similares

Extent, trends, and determinants of controller/reliever balance in mild asthma: a 14-year population-based study
por: Khakban, Amir, et al.
Publicado: (2019)

Trends in oral corticosteroids use in severe asthma: a 14-year population-based study
por: Sadatsafavi, Mohsen, et al.
Publicado: (2021)

Complementary and alternative asthma treatments and their association with asthma control: a population-based study
por: Chen, Wenjia, et al.
Publicado: (2013)

Predictors of inappropriate and excessive use of reliever medications in asthma: a 16-year population-based study
por: Tavakoli, Hamid, et al.
Publicado: (2018)

Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US
por: Zafari, Zafar, et al.
Publicado: (2018)

Post-hospital syndrome in adults with asthma: a case-crossover study
por: Sadatsafavi, Mohsen, et al.
Publicado: (2013)

Cost-Effectiveness of Bronchial Thermoplasty, Omalizumab, and Standard Therapy for Moderate-to-Severe Allergic Asthma
por: Zafari, Zafar, et al.
Publicado: (2016)

Heterogeneity's ruses: the neglected role of between-individual variability in longitudinal studies of COPD exacerbations
por: Sadatsafavi, Mohsen, et al.
Publicado: (2014)

Direct costs of overdiagnosed asthma: a longitudinal, population-based cohort study in British Columbia, Canada
por: Ng, Bryan, et al.
Publicado: (2019)

The economics of precision health: preventing air pollution-induced exacerbation in asthma
por: Mohammadi, Tima, et al.
Publicado: (2021)

Trends in prescriptions and costs of inhaled medications in chronic obstructive pulmonary disease: a 19-year population-based study from Canada
por: Tavakoli, Hamid, et al.
Publicado: (2019)

Trends in Asthma-Related Direct Medical Costs from 2002 to 2007 in British Columbia, Canada: A Population Based-Cohort Study
por: Bedouch, Pierrick, et al.
Publicado: (2012)

Correction: Trends in Asthma-Related Direct Medical Costs from 2002 to 2007 in British Columbia, Canada: A Population Based-Cohort Study
por: Bedouch, Pierrick, et al.
Publicado: (2013)

Can we predict who will benefit most from biologics in severe asthma? A post-hoc analysis of two phase 3 trials
por: Chen, Wenjia, et al.
Publicado: (2023)

Concurrent physician-diagnosed asthma and chronic obstructive pulmonary disease: A population study of prevalence, incidence and mortality
por: Kendzerska, Tetyana, et al.
Publicado: (2017)

A parametric model to jointly characterize rate, duration, and severity of exacerbations in episodic diseases
por: Safari, Abdollah, et al.
Publicado: (2023)

The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada
por: Sadatsafavi, Mohsen, et al.
Publicado: (2021)

COVID-19 mRNA Vaccines and Interstitial Lung Disease Exacerbation: Causation or Just a Temporal Association?
por: Ehteshami-Afshar, Solmaz, et al.
Publicado: (2022)

The association between previous and future severe exacerbations of chronic obstructive pulmonary disease: Updating the literature using robust statistical methodology
por: Sadatsafavi, Mohsen, et al.
Publicado: (2018)

Asthma guidelines: Global to local
por: FitzGerald, J. Mark
Publicado: (2009)

Gender modifies the effect of body mass index on lung function decline in mild-to-moderate COPD patients: a pooled analysis
por: Chen, Wenjia, et al.
Publicado: (2021)

The Projected Economic and Health Burden of Uncontrolled Asthma in the United States
por: Yaghoubi, Mohsen, et al.
Publicado: (2019)

Achieving asthma control: Providing a framework for clinicians
por: FitzGerald, J. Mark
Publicado: (2016)

Is Certolizumab Pegol Safe and Effective in the Treatment of Patients with Moderate to Severe Crohn’s Disease? A Meta-analysis of Controlled Clinical Trials
por: Nikfar, Shekoufeh, et al.
Publicado: (2013)

Cardiovascular Comorbidities in Psoriatic Disease
por: Szentpetery, Agnes, et al.
Publicado: (2019)

Current recommendations for the treatment of mild asthma
por: Shahidi, Neal, et al.
Publicado: (2010)

The role of asthma guidelines in achieving current control and reducing future risk
por: FitzGerald, J. Mark
Publicado: (2012)

Empowering pharmacists in asthma management through interactive SMS (EmPhAsIS): study protocol for a randomized controlled trial
por: De Vera, Mary A, et al.
Publicado: (2014)

A systematic review and meta-analysis of the effects of infliximab on the rate of colectomy and post-operative complications in patients with inflammatory bowel disease
por: Ehteshami-Afshar, Solmaz, et al.
Publicado: (2011)

Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD
por: Johnson, Kate M, et al.
Publicado: (2018)

Future Impact of Various Interventions on the Burden of COPD in Canada: A Dynamic Population Model
por: Najafzadeh, Mehdi, et al.
Publicado: (2012)

Malignant hyperthermia in severe COVID-19: 2 case reports
por: Ehteshami-Afshar, Solmaz, et al.
Publicado: (2021)

Long-Term Natural History of Severe Asthma Exacerbations and Their Impact on the Disease Course
por: Lee, Tae Yoon, et al.
Publicado: (2022)

Antibiotic consumption in children prior to diagnosis of asthma
por: Marra, Fawziah, et al.
Publicado: (2011)

Correction to: Does pulmonary subspecialty referral from primary care affect the adherence to vaccination recommendations in COPD patients?
por: Ehteshami‑Afshar, Solmaz, et al.
Publicado: (2021)

Does pulmonary subspecialty referral from primary care affect the adherence to vaccination recommendations in COPD patients?
por: Ehteshami-Afshar, Solmaz, et al.
Publicado: (2021)

A systematic review of economic evaluations of therapy in asthma
por: Bahadori, Katayoun, et al.
Publicado: (2010)

Asthma and COPD Overlap Syndrome (ACOS): A Systematic Review and Meta Analysis
por: Alshabanat, A., et al.
Publicado: (2015)

Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management
por: Kaplan, Alan, et al.
Publicado: (2020)

Statin use and lung cancer risk in chronic obstructive pulmonary disease patients: a population-based cohort study
por: Raymakers, AJN, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dgqehd5em93ur4q82pb4896o8p